Literature DB >> 3495469

The place of elective vitrectomy in the management of patients with Candida endophthalmitis.

T Barrie.   

Abstract

A general review of the treatment of Candida endophthalmitis is undertaken, with particular emphasis on the efficacy of various drugs currently in use. Their absorption by the eye when given systemically is also considered. The limitations of medical treatment for this condition are discussed and the theoretical reasons for vitrectomy considered. Six cases that underwent vitrectomy are reviewed, and the indications for vitrectomy in Candida endophthalmitis are discussed. A tentative overall plan for the management of such cases is given.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3495469     DOI： 10.1007/BF02160341

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


  30 in total

1.  Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers.

Authors:  J R Robertson; A B Bucknall; P D Welsby; J J Roberts; J M Inglis; J F Peutherer; R P Brettle
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

2.  Intravitreal amphotericin B treatment of experimental fungal endophthalmitis.

Authors:  A J Axelrod; G A Peyman
Journal:  Am J Ophthalmol       Date:  1973-10       Impact factor: 5.258

3.  Amphotericin B in cryptococcal meningitis. Long-term results of treatment.

Authors:  G A Sarosi; J D Parker; I L Doto; F E Tosh
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

4.  Antifungal chemotherapy.

Authors:  J Cohen
Journal:  Lancet       Date:  1982-09-04       Impact factor: 79.321

5.  Metastatic endophthalmitis associated with injection of addictive drugs.

Authors:  H S Sugar; G H Mandell; J Shalev
Journal:  Am J Ophthalmol       Date:  1971-05       Impact factor: 5.258

Review 6.  Prevention of blindness in diabetic retinopathy.

Authors:  E M Kohner; P J Barry
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

Review 7.  Strategies in the treatment of systemic fungal infections.

Authors:  G Medoff; G S Kobayashi
Journal:  N Engl J Med       Date:  1980-01-17       Impact factor: 91.245

8.  Successful treatment of Candida albicans endophthalmitis with intravitreal amphotericin B.

Authors:  L E Perraut; L E Perraut; B Bleiman; J Lyons
Journal:  Arch Ophthalmol       Date:  1981-09

9.  Candida endophthalmitis and drug abuse.

Authors:  K H Tarr
Journal:  Aust J Ophthalmol       Date:  1980-11

10.  Candida endophthalmitis in a heroin addict: a case report.

Authors:  J F Salmon; B M Partridge; D J Spalton
Journal:  Br J Ophthalmol       Date:  1983-05       Impact factor: 4.638
View more
  4 in total

1.  Outcomes, impact on management, and costs of fungal eye disease consults in a tertiary care setting.

Authors:  Devon H Ghodasra; Kian Eftekhari; Ankoor R Shah; Brian L VanderBeek
Journal:  Ophthalmology       Date:  2014-08-10       Impact factor: 12.079

2.  Relation between stage of endogenous fungal endophthalmitis and prognosis.

Authors:  Hiroshi Takebayashi; Atsushi Mizota; Minoru Tanaka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-06       Impact factor: 3.117

3.  Fundoscopy screening for intraocular candida in patients with positive blood cultures-is it justified?

Authors:  Mariam El-Abiary; Brian Jones; Graeme Williams; David Lockington
Journal:  Eye (Lond)       Date:  2018-07-06       Impact factor: 3.775

4.  Endogenous candida endophthalmitis.

Authors:  A H Chignell
Journal:  J R Soc Med       Date:  1992-12       Impact factor: 18.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.